Disorders of vitamin B9 and B12 metabolism in children: prevalence, selected clinical aspects, and optimization of diagnostic approaches
Abstract
Disorders of vitamin B9 and B12 metabolism is an important problem in modern pediatrics due to its prevalence, nonspecific clinical manifestations, and diagnostic difficulties. Aim – to evaluate the prevalence and features of vitamin B9 and B12 metabolic disorders in school-aged children, to assess the role of hyperhomocysteinemia in clinical manifestations, and to improve diagnostic approaches. We analyzed 100 scientific publications (70% PubMed and Google Scholar) and examined 84 children aged 6-16 years observed at Ivano-Frankivsk Regional Children’s Clinical Hospital (59.5%) and the medical center “Doctor Tsaruk” (40.5%) during 2023-2026. Serum concentrations of vitamins B9 and B12 were determined using enzyme-linked immunosorbent assay, plasma homocysteine concentration was measured by high-performance liquid chromatography, and MTHFR C677T and MTRR A66G polymorphisms were analyzed using polymerase chain reaction. Cognitive status was assessed using a Likert-scale questionnaire developed by the authors. Vitamin B12 and B9 deficiency in Ukraine ranges from 13.5-18.9%. The main clinical features were fatigue (85.7%) and weakness (77.4%). Cognitive disorders were significantly more frequent in children aged 6-12 years than in adolescents (93.1% vs 25.0%; χ²=34.8; p<0.0001). Adolescents more often reported memory impairment (54.5%) and reduced attention (45.4%). Isolated vitamin B12 deficiency was found in 54.8% of children, vitamin B9 deficiency – in 29.7%, and combined deficiency – in 13%. Mean corpuscular volume was higher in the combined deficiency group (104.8±7.1 fL), indicating macrocytic changes. Methylmalonic acid levels were increased in B12-deficient and combined groups. The MTHFR C677T homozygous variant was associated with higher homocysteine levels (r=0.64; p<0.0. Children with combined deficiency showed significantly worse cognitive performance than those with isolated deficiency (p<0.05). Thus, Vitamin B9 and B12 deficiency is an important risk factor for cognitive impairment in children. Combined deficiency has a more severe clinical impact which underscores the need for early diagnosis and the consideration of genetic factors. A pathogenetically grounded approach makes it possible to improve treatment outcomes and the prevention of neurological complications.